↓ Skip to main content

Harnessing the immune system in acute myeloid leukaemia

Overview of attention for article published in Critical Reviews in Oncology/Hematology, May 2016
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
4 X users

Citations

dimensions_citation
85 Dimensions

Readers on

mendeley
179 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Harnessing the immune system in acute myeloid leukaemia
Published in
Critical Reviews in Oncology/Hematology, May 2016
DOI 10.1016/j.critrevonc.2016.04.020
Pubmed ID
Authors

Rebecca Austin, Mark J. Smyth, Steven W. Lane

Abstract

Acute myeloid leukaemia (AML) is an aggressive blood cancer caused by the proliferation of immature myeloid cells. The genetic abnormalities underlying AML affect signal transduction pathways, transcription factors and epigenetic modifiers. In solid tumours, it is emerging that the genetic landscape of the tumour has a direct effect on the anti-tumour immune responses and response to immunotherapeutic treatment. However, there remains little information as to whether genetic abnormalities affect anti-leukemic immune responses. This review discusses current knowledge of AML antigens and immune responses to AML with a particular focus on the role of T cells and natural killer cells. Understanding immune responses to AML has implications for the development and use of immunotherapies to treat AML patients with distinct genetic abnormalities.

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 179 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Australia 1 <1%
Unknown 178 99%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 30 17%
Student > Postgraduate 29 16%
Researcher 27 15%
Student > Bachelor 18 10%
Student > Doctoral Student 8 4%
Other 22 12%
Unknown 45 25%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 45 25%
Medicine and Dentistry 32 18%
Agricultural and Biological Sciences 27 15%
Immunology and Microbiology 17 9%
Unspecified 2 1%
Other 9 5%
Unknown 47 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 July 2016.
All research outputs
#16,045,990
of 25,368,786 outputs
Outputs from Critical Reviews in Oncology/Hematology
#1,300
of 1,946 outputs
Outputs of similar age
#180,362
of 323,893 outputs
Outputs of similar age from Critical Reviews in Oncology/Hematology
#20
of 30 outputs
Altmetric has tracked 25,368,786 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,946 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.8. This one is in the 30th percentile – i.e., 30% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 323,893 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 30 others from the same source and published within six weeks on either side of this one. This one is in the 33rd percentile – i.e., 33% of its contemporaries scored the same or lower than it.